MedPath

The Moms Online Video Exercise Study

Not Applicable
Completed
Conditions
Sedentary Lifestyle
Registration Number
NCT02805140
Lead Sponsor
University of California, San Francisco
Brief Summary

The purpose of this study is to test feasibility and acceptability of an online platform that uses mobile apps and videoconferencing tools to increase activity levels in mothers with young children.

Detailed Description

The investigators are testing the feasibility and acceptability of a digital health platform using a randomized parallel wait-list control design for mothers with young children. The platform incorporates home based supportive group exercise sessions using video conferencing tools, shared online activity tracking and exercise mobile apps for individualized exercise routines will help mothers increase their physical activity levels and be successful at maintaining this increase.

The intervention arm consists of two main parts: home based video conferencing virtual exercise sessions and mobile exercise apps, which women use to tailor exercise routines to their own skill level and preferences. Both arms will receive an activity monitor that they collect continuous activity data throughout the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
64
Inclusion Criteria
  • Mother to at least one child that is less than 18 years old
  • Owns a smart phone (iPhone or Android) and can download mobile applications
  • Sufficient data to use mobile applications on a mobile device
  • Owns a mobile device with a web camera
Exclusion Criteria
  • Inability to provide informed consent
  • Inability to speak or understand English
  • Any medical restrictions where vigorous activity is not recommended
  • Any history of heart conditions including cardiovascular disease or coronary artery disease
  • Any history of heart conditions including cardiovascular disease or coronary artery disease
  • Meets federal guidelines for exercise for either aerobic (150 minutes of moderate activity per week, 75 minutes of vigorous activity per week, or some combination)
  • Pregnant or planning to get pregnant during study duration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Feasibility of recruitmentEnd of 8 week recruitment period

Recruiting 75% of goal of 38 participants

Acceptability of study proceduresEnd of 8 week intervention period

We will consider at least 75% of participants being "satisfied" or "very satisfied" (using a Likert scale) in the overall study evaluation to indicate acceptability of the study materials.

Change in minutes per week of moderate-to-vigorous physical activity0 weeks, 8 weeks

Active minutes (past 7 days) using self report through Active Australia Survey

Secondary Outcome Measures
NameTimeMethod
Change in exercise enjoyment0 weeks, 8 weeks

Using Sallis Short Form 3 item exercise enjoyment scale, the investigators will measure changes in exercise enjoyment

Change in exercise social support0 weeks, 8 weeks

Using Sallis Short Form 3 item exercise social support scale, the investigators will measure changes in exercise social support

Change in global health0 weeks, 8 weeks

Using NIH Patient Reported Outcome Measurement System (PROMIS) Global Health 7 item measure, the investigators will measure overall changes in global health

Change in fatigue0 weeks, 8 weeks

Using NIH Patient Reported Outcome Measurement System (PROMIS) Global Health 4 item measure, the investigators will measure overall changes in fatigue

Change in exercise self efficacy0 weeks, 8 weeks

Using Sallis Short Form 3 item self efficacy scale, the investigators will measure changes in exercise self efficacy

Change in weight0 weeks, 8 weeks

Difference in pounds gained or lost in lbs measured by self report via survey

Trial Locations

Locations (1)

UCSF

🇺🇸

San Francisco, California, United States

UCSF
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.